Genprex, Inc. Gains 21.69%

Fri 21 Feb 20 at 05:30 PM
Genprex, Inc. Gains 21.69%

Genprex, Inc. (GNPX:NASDAQ) rocketted at $5.33, representing a gain of 21.7%. The stock appeared on our News Catalysts scanner on Tue 11 Feb 20 at 02:17 PM in the 'AGREEMENT' category. From Thu 30 Jan 20, the stock recorded 57.14% Up Days and 53.33% Green Days

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.